Research

Life science innovation
Home / Innovation Hub / Research

Exploring new worlds and broadening the boundaries of care

ab medica currently invests more than 3% of its turnover in scientific research, consolidating its position as a company open to the exchange of ideas and with a focus on significant research projects.

By sharing experiences with the other companies in the group and bolstering relationships with universities, research centres and international scientific laboratories, ab medica has expanded its knowledge of several key research areas, including:

  • Digital Therapeutics
  • Telemedicine
  • Artificial Intelligence
  • Tissue engineering
  • Genomics
  • Neuroscience
  • Wearable technology
HIGHLIGHT

DEGRAPOL

Degrapol is an innovative polyurethane polymer that is both biocompatible and biodegradable. These two properties make Degrapol the ideal material for implantable scaffolds used to repair or replace damaged tissue.
It was developed by Zurich’s Polytechnic laboratories (ETH Zürich). It was then synthesised by ab medica’s labs: by modifying its formulation, its mechanical properties can be modulated to control the degradation rate of the final product.

Because it is hydrophilic and degrades without changing the pH of the implantation site, Degrapol seamlessly integrates and interacts with biological tissue. Its physical and mechanical properties make it similar to many types of cellular tissue, muscles, heart valves and blood vessels, while its versatility means it can be easily manipulated to create complex structures.

A research project on heart valves and small arteries is currently ongoing in collaboration with the University of Cape Town’s Chris Barnard Division of Cardiothoracic Surgery.

HIGHLIGHT

HELMATE

Body-worn, wireless device for the continuous acquisition of 8 EEG channels at point of care taken from dry electrodes positioned on the patient’s scalp. Device could be configured in Real Time mode and in Holter both in professional healthcare facilities and in home healthcare. Ab medica EEG monitoring device is CE marked as medical device in class IIA.

Collaborations

ab medica’s Innovation Hub is collaborating in innovative research projects with several prestigious institutes, including: the University of Cape Town, the Polytechnic University of Milan, the National Research Council of Italy (CNR), the University of Pisa and the Sant’Anna School of Advanced Studies of Pisa.

For more information write us

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.